Mupirocin resistance among MRSA surveillance isolates from neonatal intensive care unit under 10 year-search and destroy policy compared to

Dissemination of Methicillin-Resistant Staphylococcus aureus Sequence Type 764 Isolates with Mupirocin Resistance in China

“…In this study, 10.07% of patients had MRSA isolates that were phenotypically either low-level MR-MRSA or high-level MRSA, with the prevalence of low-level MR-MRSA (5.7%) being higher than that of high-level MR-MRSA (4.4%). This is in accordance with the findings of Kim et al ( 10 ), Chaturvedi et al ( 11 ), and Ohadian Moghadam et al ( 12 ), who reported that the incidence rates of mupirocin-resistant isolates were 9.5%, 18.3%, and 10.26%, respectively. Liu et al reported that 53/803 MRSA isolates (6.6%) were confirmed to be highly resistant to mupirocin, which was significantly lower than the rate in the present study ( 13 ).…”

Outbreak of Methicillin Resistant Staphylococcus aureus in Neonatal Intensive Care Unit in a Tertiary Care Hospital in Kolkata

“…The Mupirocin resistance is 25% in this study as reported elsewhere. [12] Clindamycin is 58% sensitive in this study. So, Clindamycin is proposed as effective drug as supported in other studies.…”

Mupirocin Resistance in Staphylococcus Aureus in a Tertiary Care Hospital of South India – A Prospective Study

“…The interesting finding of our study is the presence of mupirocin resistance in MSSA almost equal to that in MRSA. According to a study by Kim et al mupirocin resistance was seen in 39 isolates of S. aureus (7.8%) which comprised 30 (9.5%) MRSA and 9 (4.9%) MSSA [25]. Another study by McNeil et al reported 14.7% incidence of mupirocin resistance among S. aureus.…”